ADIPOQ and metabolic dysfunction-associated steatotic liver disease: A significant inverse correlation was found between plasma adiponectin and CIMT in obese patients with NAFLD (p < 0.05), but no significant inverse correlation could be established between plasma adiponectin and CIMT in patients with T2DM (Table 4).